Viracta Therapeutics
VIRX
#11305
Rank
A$0.58 M
Marketcap
A$0.01478
Share price
0.00%
Change (1 day)
-4.57%
Change (1 year)

Earnings for Viracta Therapeutics (VIRX)

Earnings in 2024 (TTM): -A$64.19 Million

According to Viracta Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$77.14 Million a decrease over its 2022 earnings that were of -A$74.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viracta Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$64.19 Million-16.79%
2023 -A$77.14 Million3.78%
2022 -A$74.33 Million-57.13%
2021 -A$0.18 Billion503.47%
2020 -A$28.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion 260.69%๐Ÿ‡บ๐Ÿ‡ธ USA